| Identification | Back Directory | [Name]
Sonepcizumab (anti-Sphingosine-1-phosphate) | [CAS]
1031360-18-5 | [Synonyms]
Sonepcizumab (anti-Sphingosine-1-phosphate) |
| Hazard Information | Back Directory | [Uses]
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1]. | [References]
[1] Pal SK, et al. A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 2017 Feb 15;123(4):576-582. DOI:10.1002/cncr.30393 |
|
|